Difference between revisions of "Vanhaesebroeck B, et al. Nat. Rev. Mol. Cell. Biol. (2010) cited as Ref 353 in DOI: 10.1038/s41392-020-0110-5 (Q9616)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 329-341, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Bilanges B, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Bilanges B | ||
| Property / Fourth Author string: Bilanges B / rank | |||
| + | Normal rank | ||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Vanhaesebroeck B, et al. Nat. Rev. Mol. Cell. Biol. (2010) cited as Ref 353 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Vanhaesebroeck B
0 references
GuillermetGuibert J
0 references
Graupera M
0 references
2010
0 references
Nat. Rev. Mol. Cell. Biol.
0 references
11
0 references
The emerging mechanisms of isoform-specific PI3K signalling (English)
0 references
329-341
0 references
Bilanges B
0 references
